The company is a Korea-based company primarily engaged in the provision of clinical trial services. The Company is a contract research organization (CRO) that provides clinical trial related services to pharmaceutical companies and bio ventures. The Company also provides post-marketing research (rPMS) services. The Company was established on October 31, 2003. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on June 3, 2021.
Headquarters
711 Royal Bldg., 5, Dangju-Dong, Jongno-Gu
Seoul; Seoul;
Contact Details: Purchase the Adm Korea Inc. report to view the information.
Website: http://www.admkorea.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service